1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Infective Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Anti-Infective Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Infective Treatment Market Perspective (2017-2028)
2.2 Anti-Infective Treatment Growth Trends by Region
2.2.1 Anti-Infective Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-Infective Treatment Historic Market Size by Region (2017-2022)
2.2.3 Anti-Infective Treatment Forecasted Market Size by Region (2023-2028)
2.3 Anti-Infective Treatment Market Dynamics
2.3.1 Anti-Infective Treatment Industry Trends
2.3.2 Anti-Infective Treatment Market Drivers
2.3.3 Anti-Infective Treatment Market Challenges
2.3.4 Anti-Infective Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Infective Treatment Players by Revenue
3.1.1 Global Top Anti-Infective Treatment Players by Revenue (2017-2022)
3.1.2 Global Anti-Infective Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Anti-Infective Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Infective Treatment Revenue
3.4 Global Anti-Infective Treatment Market Concentration Ratio
3.4.1 Global Anti-Infective Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Infective Treatment Revenue in 2021
3.5 Anti-Infective Treatment Key Players Head office and Area Served
3.6 Key Players Anti-Infective Treatment Product Solution and Service
3.7 Date of Enter into Anti-Infective Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Infective Treatment Breakdown Data by Type
4.1 Global Anti-Infective Treatment Historic Market Size by Type (2017-2022)
4.2 Global Anti-Infective Treatment Forecasted Market Size by Type (2023-2028)
5 Anti-Infective Treatment Breakdown Data by Application
5.1 Global Anti-Infective Treatment Historic Market Size by Application (2017-2022)
5.2 Global Anti-Infective Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-Infective Treatment Market Size (2017-2028)
6.2 North America Anti-Infective Treatment Market Size by Country (2017-2022)
6.3 North America Anti-Infective Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anti-Infective Treatment Market Size (2017-2028)
7.2 Europe Anti-Infective Treatment Market Size by Country (2017-2022)
7.3 Europe Anti-Infective Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Treatment Market Size (2017-2028)
8.2 Asia-Pacific Anti-Infective Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Anti-Infective Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anti-Infective Treatment Market Size (2017-2028)
9.2 Latin America Anti-Infective Treatment Market Size by Country (2017-2022)
9.3 Latin America Anti-Infective Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Treatment Market Size (2017-2028)
10.2 Middle East & Africa Anti-Infective Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Anti-Infective Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Anti-Infective Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Anti-Infective Treatment Introduction
11.2.4 Merck Revenue in Anti-Infective Treatment Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anti-Infective Treatment Introduction
11.3.4 Pfizer Revenue in Anti-Infective Treatment Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Anti-Infective Treatment Introduction
11.4.4 Novartis AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.4.5 Novartis AG Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Detail
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Anti-Infective Treatment Introduction
11.5.4 Gilead Sciences Revenue in Anti-Infective Treatment Business (2017-2022)
11.5.5 Gilead Sciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Anti-Infective Treatment Introduction
11.6.4 Abbott Revenue in Anti-Infective Treatment Business (2017-2022)
11.6.5 Abbott Recent Development
11.7 Wyeth
11.7.1 Wyeth Company Detail
11.7.2 Wyeth Business Overview
11.7.3 Wyeth Anti-Infective Treatment Introduction
11.7.4 Wyeth Revenue in Anti-Infective Treatment Business (2017-2022)
11.7.5 Wyeth Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Detail
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Anti-Infective Treatment Introduction
11.8.4 Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2017-2022)
11.8.5 Sanofi-Aventis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Anti-Infective Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2017-2022)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Johnson
11.10.1 Johnson Company Detail
11.10.2 Johnson Business Overview
11.10.3 Johnson Anti-Infective Treatment Introduction
11.10.4 Johnson Revenue in Anti-Infective Treatment Business (2017-2022)
11.10.5 Johnson Recent Development
11.11 Roche Pharma AG
11.11.1 Roche Pharma AG Company Detail
11.11.2 Roche Pharma AG Business Overview
11.11.3 Roche Pharma AG Anti-Infective Treatment Introduction
11.11.4 Roche Pharma AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.11.5 Roche Pharma AG Recent Development
11.12 Nanosphere
11.12.1 Nanosphere Company Detail
11.12.2 Nanosphere Business Overview
11.12.3 Nanosphere Anti-Infective Treatment Introduction
11.12.4 Nanosphere Revenue in Anti-Infective Treatment Business (2017-2022)
11.12.5 Nanosphere Recent Development
11.13 NanoViricides
11.13.1 NanoViricides Company Detail
11.13.2 NanoViricides Business Overview
11.13.3 NanoViricides Anti-Infective Treatment Introduction
11.13.4 NanoViricides Revenue in Anti-Infective Treatment Business (2017-2022)
11.13.5 NanoViricides Recent Development
11.14 Novabay Pharmaceuticals
11.14.1 Novabay Pharmaceuticals Company Detail
11.14.2 Novabay Pharmaceuticals Business Overview
11.14.3 Novabay Pharmaceuticals Anti-Infective Treatment Introduction
11.14.4 Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022)
11.14.5 Novabay Pharmaceuticals Recent Development
11.15 Obetech
11.15.1 Obetech Company Detail
11.15.2 Obetech Business Overview
11.15.3 Obetech Anti-Infective Treatment Introduction
11.15.4 Obetech Revenue in Anti-Infective Treatment Business (2017-2022)
11.15.5 Obetech Recent Development
11.16 Optimer Pharmaceuticals
11.16.1 Optimer Pharmaceuticals Company Detail
11.16.2 Optimer Pharmaceuticals Business Overview
11.16.3 Optimer Pharmaceuticals Anti-Infective Treatment Introduction
11.16.4 Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022)
11.16.5 Optimer Pharmaceuticals Recent Development
11.17 Basilea Pharmaceutica AG
11.17.1 Basilea Pharmaceutica AG Company Detail
11.17.2 Basilea Pharmaceutica AG Business Overview
11.17.3 Basilea Pharmaceutica AG Anti-Infective Treatment Introduction
11.17.4 Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2017-2022)
11.17.5 Basilea Pharmaceutica AG Recent Development
11.18 Daiichi Sankyo
11.18.1 Daiichi Sankyo Company Detail
11.18.2 Daiichi Sankyo Business Overview
11.18.3 Daiichi Sankyo Anti-Infective Treatment Introduction
11.18.4 Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2017-2022)
11.18.5 Daiichi Sankyo Recent Development
11.19 MerLion Pharma
11.19.1 MerLion Pharma Company Detail
11.19.2 MerLion Pharma Business Overview
11.19.3 MerLion Pharma Anti-Infective Treatment Introduction
11.19.4 MerLion Pharma Revenue in Anti-Infective Treatment Business (2017-2022)
11.19.5 MerLion Pharma Recent Development
11.20 Theravance
11.20.1 Theravance Company Detail
11.20.2 Theravance Business Overview
11.20.3 Theravance Anti-Infective Treatment Introduction
11.20.4 Theravance Revenue in Anti-Infective Treatment Business (2017-2022)
11.20.5 Theravance Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-Infective Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Anti-Infective Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Anti-Infective Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-Infective Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anti-Infective Treatment Market Share by Region (2017-2022)
Table 8. Global Anti-Infective Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anti-Infective Treatment Market Share by Region (2023-2028)
Table 10. Anti-Infective Treatment Market Trends
Table 11. Anti-Infective Treatment Market Drivers
Table 12. Anti-Infective Treatment Market Challenges
Table 13. Anti-Infective Treatment Market Restraints
Table 14. Global Anti-Infective Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anti-Infective Treatment Market Share by Players (2017-2022)
Table 16. Global Top Anti-Infective Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Treatment as of 2021)
Table 17. Ranking of Global Top Anti-Infective Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anti-Infective Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-Infective Treatment Product Solution and Service
Table 21. Date of Enter into Anti-Infective Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Infective Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anti-Infective Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Anti-Infective Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anti-Infective Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Anti-Infective Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Anti-Infective Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Anti-Infective Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Anti-Infective Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Anti-Infective Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Anti-Infective Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Anti-Infective Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Anti-Infective Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. GlaxoSmithKline Company Detail
Table 42. GlaxoSmithKline Business Overview
Table 43. GlaxoSmithKline Anti-Infective Treatment Product
Table 44. GlaxoSmithKline Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 45. GlaxoSmithKline Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Anti-Infective Treatment Product
Table 49. Merck Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Anti-Infective Treatment Product
Table 54. Pfizer Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Novartis AG Company Detail
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Anti-Infective Treatment Product
Table 59. Novartis AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Gilead Sciences Company Detail
Table 62. Gilead Sciences Business Overview
Table 63. Gilead Sciences Anti-Infective Treatment Product
Table 64. Gilead Sciences Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 65. Gilead Sciences Recent Development
Table 66. Abbott Company Detail
Table 67. Abbott Business Overview
Table 68. Abbott Anti-Infective Treatment Product
Table 69. Abbott Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Wyeth Company Detail
Table 72. Wyeth Business Overview
Table 73. Wyeth Anti-Infective Treatment Product
Table 74. Wyeth Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 75. Wyeth Recent Development
Table 76. Sanofi-Aventis Company Detail
Table 77. Sanofi-Aventis Business Overview
Table 78. Sanofi-Aventis Anti-Infective Treatment Product
Table 79. Sanofi-Aventis Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 80. Sanofi-Aventis Recent Development
Table 81. Bristol-Myers Squibb Company Detail
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Anti-Infective Treatment Product
Table 84. Bristol-Myers Squibb Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Johnson Company Detail
Table 87. Johnson Business Overview
Table 88. Johnson Anti-Infective Treatment Product
Table 89. Johnson Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 90. Johnson Recent Development
Table 91. Roche Pharma AG Company Detail
Table 92. Roche Pharma AG Business Overview
Table 93. Roche Pharma AG Anti-Infective TreatmentProduct
Table 94. Roche Pharma AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 95. Roche Pharma AG Recent Development
Table 96. Nanosphere Company Detail
Table 97. Nanosphere Business Overview
Table 98. Nanosphere Anti-Infective TreatmentProduct
Table 99. Nanosphere Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 100. Nanosphere Recent Development
Table 101. NanoViricides Company Detail
Table 102. NanoViricides Business Overview
Table 103. NanoViricides Anti-Infective TreatmentProduct
Table 104. NanoViricides Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 105. NanoViricides Recent Development
Table 106. Novabay Pharmaceuticals Company Detail
Table 107. Novabay Pharmaceuticals Business Overview
Table 108. Novabay Pharmaceuticals Anti-Infective TreatmentProduct
Table 109. Novabay Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 110. Novabay Pharmaceuticals Recent Development
Table 111. Obetech Company Detail
Table 112. Obetech Business Overview
Table 113. Obetech Anti-Infective TreatmentProduct
Table 114. Obetech Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 115. Obetech Recent Development
Table 116. Optimer Pharmaceuticals Company Detail
Table 117. Optimer Pharmaceuticals Business Overview
Table 118. Optimer Pharmaceuticals Anti-Infective TreatmentProduct
Table 119. Optimer Pharmaceuticals Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 120. Optimer Pharmaceuticals Recent Development
Table 121. Basilea Pharmaceutica AG Company Detail
Table 122. Basilea Pharmaceutica AG Business Overview
Table 123. Basilea Pharmaceutica AG Anti-Infective TreatmentProduct
Table 124. Basilea Pharmaceutica AG Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 125. Basilea Pharmaceutica AG Recent Development
Table 126. Daiichi Sankyo Company Detail
Table 127. Daiichi Sankyo Business Overview
Table 128. Daiichi Sankyo Anti-Infective TreatmentProduct
Table 129. Daiichi Sankyo Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 130. Daiichi Sankyo Recent Development
Table 131. MerLion Pharma Company Detail
Table 132. MerLion Pharma Business Overview
Table 133. MerLion Pharma Anti-Infective TreatmentProduct
Table 134. MerLion Pharma Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 135. MerLion Pharma Recent Development
Table 136. Theravance Company Detail
Table 137. Theravance Business Overview
Table 138. Theravance Anti-Infective TreatmentProduct
Table 139. Theravance Revenue in Anti-Infective Treatment Business (2017-2022) & (US$ Million)
Table 140. Theravance Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Infective Treatment Market Share by Type: 2021 VS 2028
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Anti-Infective Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Drugs Store Case Studies
Figure 7. Other Case Studies
Figure 8. Anti-Infective Treatment Report Years Considered
Figure 9. Global Anti-Infective Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Anti-Infective Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Anti-Infective Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Anti-Infective Treatment Market Share by Players in 2021
Figure 13. Global Top Anti-Infective Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Anti-Infective Treatment Revenue in 2021
Figure 15. North America Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Anti-Infective Treatment Market Share by Country (2017-2028)
Figure 17. United States Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Anti-Infective Treatment Market Share by Country (2017-2028)
Figure 21. Germany Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Anti-Infective Treatment Market Share by Region (2017-2028)
Figure 29. China Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Anti-Infective Treatment Market Share by Country (2017-2028)
Figure 37. Mexico Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Anti-Infective Treatment Market Share by Country (2017-2028)
Figure 41. Turkey Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Anti-Infective Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. GlaxoSmithKline Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 44. Merck Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 45. Pfizer Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 46. Novartis AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 47. Gilead Sciences Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 48. Abbott Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 49. Wyeth Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 50. Sanofi-Aventis Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 52. Johnson Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 53. Roche Pharma AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 54. Nanosphere Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 55. NanoViricides Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 56. Novabay Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 57. Obetech Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 58. Optimer Pharmaceuticals Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 59. Basilea Pharmaceutica AG Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 61. MerLion Pharma Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 62. Theravance Revenue Growth Rate in Anti-Infective Treatment Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Merck Pfizer Novartis AG Gilead Sciences Abbott Wyeth Sanofi-Aventis Bristol-Myers Squibb Johnson Roche Pharma AG Nanosphere NanoViricides Novabay Pharmaceuticals Obetech Optimer Pharmaceuticals Basilea Pharmaceutica AG Daiichi Sankyo MerLion Pharma Theravance